about
Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis BEstablishment of a doxycycline-regulated cell line with inducible, doubly-stable expression of the wild-type p53 gene from p53-deleted hepatocellular carcinoma cellsHepatitis C virus nonstructural region 5A protein is a potent transcriptional activatorEffect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trialIdentification of two novel CT antigens and their capacity to elicit antibody response in hepatocellular carcinoma patientsCurrent role of ultrasound for the management of hepatocellular carcinomaEvolution of genetic abnormalities in hepatocellular carcinomas demonstrated by DNA fingerprinting.Paradoxical pro-invasive effect of the serine proteinase inhibitor tissue factor pathway inhibitor-2 on human hepatocellular carcinoma cells.Clonal analysis of micronodules in virus C-induced liver cirrhosis using laser capture microdissection (LCM) and HUMARA assay.A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells.Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis.Distribution of constitutive (COX-1) and inducible (COX-2) cyclooxygenase in postviral human liver cirrhosis: a possible role for COX-2 in the pathogenesis of liver cirrhosis.Hepatocellular carcinoma: clinicopathological profile and challenges of management in a resource-limited setting.Recent developments in the first detection of hepatocellular carcinomaThe role of cyclooxygenase and lipoxygenase in cancer chemoprevention.Weak association between SEN virus viremia and liver diseaseImproved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uraciViruses and hepatocellular carcinoma.Antiproliferative and apoptotic effects of tetrandrine on different human hepatoma cell lines.Management of hepatocellular carcinoma: advances in diagnosis, treatment and prevention.Genetic polymorphism of the human organic solute carrier protein 1 (hOSCP1) gene in Japanese patients with non-viral liver carcinoma.Genetic heterogeneity of hepatocellular carcinomaGene expression profile related to the progression of preneoplastic nodules toward hepatocellular carcinoma in rats.Genomic heterogeneity in synchronous hepatocellular carcinomas.Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview.Detection of hypermethylation of the p16(INK4A) gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virusIndications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology.Augmentation effect of postprandial hyperinsulinaemia on growth of human hepatocellular carcinoma.Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosisHepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma.Transcriptional targeting of herpes simplex virus for cell-specific replication.Factors linked to longterm survival of patients with hepatocellular carcinoma accompanied by tumour thrombus in the major portal vein after surgical resection.Aberrant FHIT transcripts in hepatocellular carcinomas.Immune pathogenesis of hepatocellular carcinoma.Comparison of the efficacy of transcatheter arterial chemoembolization and sorafenib for advanced hepatocellular carcinomaLiver cirrhosis and hepatic stellate cells.Expression of MAGE-1 and -3 genes and gene products in human hepatocellular carcinoma.Immunohistochemical detection of HCV infection in patients with hepatocellular carcinoma and other liver diseasesCpG methylation of MGMT and hMLH1 promoter in hepatocellular carcinoma associated with hepatitis viral infection.Prevalence and factors affecting occurrence of type 2 diabetes mellitus in Saudi patients with chronic liver disease.
P2860
Q24248748-C76F5C61-4FEE-4213-8FA1-8469196BFBDBQ24815431-F376B4FD-99A3-4E9E-B381-3B36BAA64B2DQ27480896-E2AB18F4-C50A-4F9D-A0BC-70D007E48BBCQ28361953-8697E40F-5D4A-4FF7-8D94-2CDF8E13C641Q28975750-5D83B940-BEA4-460D-869B-6FD557C3E24AQ30488974-1BFE65EC-CD7C-4D8A-9531-B60283925603Q30806345-04AE4FCC-9572-456D-B497-1C5486B7CC3CQ30909624-403065A2-675B-4838-8426-6010D9F5B622Q30949172-504E288A-255D-49D8-B4F4-220B4B1ED3CDQ33183474-1BA5B393-1151-4611-93D8-D5C544A198C2Q33652003-601BC3B4-FDD9-48EC-8972-B6FDAEA069A3Q33976961-9ADD7B41-7317-4F2E-AF05-668E0ADAFD6EQ34000108-587BD7E9-5C50-4EB4-9BA4-7B341F8AAD42Q34055894-93B7029D-57D4-4908-8F7C-CED1DCF16076Q34153217-F42C0789-094C-402E-9CCF-5BDB78315F2CQ34196977-F7234E69-2662-4E1F-82B5-813F956FAA35Q34225481-89DC0756-BA5E-4F63-ABC3-8E1FA7ECF170Q34379306-1D8A1918-D499-406B-A882-EBEFB8DD4420Q34488399-E712261C-928B-4969-AF2D-598990E30F0AQ34733981-3DD118A7-737A-4722-92C4-2CAFF5771230Q34878913-D80AFE28-EDDF-49C2-AF10-BD7716E0CD9EQ35004899-0FA48DE6-4621-46A1-8740-0EB40FE5041FQ35070081-17253DFE-02FD-4503-9ECD-2AAC5690808FQ35357517-4475B955-DCA2-418E-8CDD-E07205A002C9Q35541482-9B315F81-DC98-46B4-A0FB-8DB3B8D1ABFBQ35565676-455E1BD7-E8B9-45A0-8BFC-FE9A2E1E9A0BQ35579265-1DD95170-8860-457C-A5B0-01CB556DB921Q35594730-32AB7991-CFB0-425D-8288-02684E99D995Q35754634-D6B95625-54EF-4417-8B28-57E3F68924E3Q35764338-DDBB7AF2-47C7-43C8-85C1-4F4381F02BB4Q35887944-E47FD496-96F8-46DF-BED3-828CBE302A8BQ36020150-53095A0A-8AAB-4DA1-B9D1-B057B479D45DQ36295106-1E356AA8-E772-4859-8E22-F963F9A403E0Q36401448-C9E0BC7B-FA4C-4711-A5DA-3AC8924189B2Q36415924-9267AF4D-D9CD-452A-AE41-842F751E9F36Q36609483-547841F2-62F4-47FE-BE5C-325BEDEC1730Q36619878-417EC807-C9BA-40FC-8CAE-685850F4DDB7Q36620270-0211FB62-90AB-4C27-80F1-A1CBCF84429CQ36649118-3A56F562-09EC-4CDB-91E7-172C3AAC63A0Q37243571-A0AB6024-8BA5-49D6-8F29-DCED419C051D
P2860
description
1992 nî lūn-bûn
@nan
1992 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Hepatocellular carcinoma: recent progress.
@ast
Hepatocellular carcinoma: recent progress.
@en
type
label
Hepatocellular carcinoma: recent progress.
@ast
Hepatocellular carcinoma: recent progress.
@en
prefLabel
Hepatocellular carcinoma: recent progress.
@ast
Hepatocellular carcinoma: recent progress.
@en
P356
P1433
P1476
Hepatocellular carcinoma: recent progress.
@en
P2093
P304
P356
10.1002/HEP.1840150532
P407
P577
1992-05-01T00:00:00Z